Page last updated: 2024-09-02

ci 988 and gv 150013x

ci 988 has been researched along with gv 150013x in 1 studies

Compound Research Comparison

Studies (ci 988)	Trials (ci 988)	Recent Studies (post-2010) (ci 988)	Studies (gv 150013x)	Trials (gv 150013x)	Recent Studies (post-2010) (gv 150013x)
147	8	14	15	0	2

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Capelli, AM; Carr, RA; Cassarà, P; Corsi, M; Curcuruto, O; Curotto, G; Dal Cin, M; Davalli, S; Donati, D; Feriani, A; Finch, H; Finizia, G; Gaviraghi, G; Marien, M; Pentassuglia, G; Polinelli, S; Ratti, E; Reggiani, A; Reggiani, AM; Tarzia, G; Tedesco, G; Tranquillini, ME; Trist, DG; Ursini, A; Van Amsterdam, FT	1

Other Studies

1 other study(ies) available for ci 988 and gv 150013x

Article	Year
Synthesis and SAR of new 5-phenyl-3-ureido-1,5-benzodiazepines as cholecystokinin-B receptor antagonists. Journal of medicinal chemistry, 2000, Oct-05, Volume: 43, Issue:20 Topics: Animals; Anti-Anxiety Agents; Benzodiazepines; Callithrix; Cerebral Cortex; Crystallography, X-Ray; Guinea Pigs; HeLa Cells; Humans; In Vitro Techniques; Membranes; Mice; Models, Molecular; Pancreas; Radioligand Assay; Rats; Receptor, Cholecystokinin A; Receptor, Cholecystokinin B; Receptors, Cholecystokinin; Stereoisomerism; Structure-Activity Relationship	2000

Article

Year

Synthesis and SAR of new 5-phenyl-3-ureido-1,5-benzodiazepines as cholecystokinin-B receptor antagonists.

Journal of medicinal chemistry, 2000, Oct-05, Volume: 43, Issue:20

Topics: Animals; Anti-Anxiety Agents; Benzodiazepines; Callithrix; Cerebral Cortex; Crystallography, X-Ray; Guinea Pigs; HeLa Cells; Humans; In Vitro Techniques; Membranes; Mice; Models, Molecular; Pancreas; Radioligand Assay; Rats; Receptor, Cholecystokinin A; Receptor, Cholecystokinin B; Receptors, Cholecystokinin; Stereoisomerism; Structure-Activity Relationship

2000